These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 34419559)

  • 1. The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
    Teyssou E; Delagrèverie H; Visseaux B; Lambert-Niclot S; Brichler S; Ferre V; Marot S; Jary A; Todesco E; Schnuriger A; Ghidaoui E; Abdi B; Akhavan S; Houhou-Fidouh N; Charpentier C; Morand-Joubert L; Boutolleau D; Descamps D; Calvez V; Marcelin AG; Soulie C
    J Infect; 2021 Oct; 83(4):e1-e3. PubMed ID: 34419559
    [No Abstract]   [Full Text] [Related]  

  • 2. The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
    Teyssou E; Soulie C; Visseaux B; Lambert-Niclot S; Ferre V; Marot S; Jary A; Sayon S; Zafilaza K; Leducq V; Schnuriger A; Abdi B; Wirden M; Houhou-Fidouh N; Charpentier C; Morand-Joubert L; Burrel S; Descamps D; Calvez V; Marcelin AG
    J Infect; 2021 Jul; 83(1):119-145. PubMed ID: 33932451
    [No Abstract]   [Full Text] [Related]  

  • 3. Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2.
    Granerud BK; Ueland T; Lind A; Søraas A; Fevang B; Steffensen AK; Al-Baldawi H; Lund-Johansen F; Aukrust P; Halvorsen B; Dahl TB; Dudman S; Müller F; Holter JC
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower nasopharyngeal viral load in young SARS-CoV-2-positive subjects.
    Salvagno GL; Henry BM; Lippi G
    Infect Dis Now; 2021 Nov; 51(8):686-688. PubMed ID: 34607081
    [No Abstract]   [Full Text] [Related]  

  • 5. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis.
    Mastrorosa I; Cozzi-Lepri A; Colavita F; Lalle E; Mazzotta V; Cimaglia C; Paulicelli J; Matusali G; Fabeni L; Carletti F; Rosati S; Vita S; Giannico G; Piselli P; Biliotti E; Moghazi SA; Mosti S; Girardi E; Nicastri E; Garbuglia AR; Maggi F; Vaia F; Antinori A
    J Clin Virol; 2022 Dec; 157():105299. PubMed ID: 36183546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.
    Bustos P; Tambley C; Acevedo A; Andrade W; Leal G; Vidal D; Roldán F; Fasce R; Ramírez E
    J Med Virol; 2021 Apr; 93(4):2439-2445. PubMed ID: 33368332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds.
    Lee BU
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load.
    Berastegui-Cabrera J; Salto-Alejandre S; Valerio M; Pérez-Palacios P; Revillas FAL; Abelenda-Alonso G; Oteo-Revuelta JA; Carretero-Ledesma M; Muñoz P; Pascual Á; Gozalo M; Rombauts A; Alba J; García-Díaz E; Rodríguez-Ferrero ML; Valiente A; Fariñas MC; Carratalà J; Santibáñez S; Camacho-Martínez P; Pachón J; Cisneros JM; Cordero E; Sánchez-Céspedes J
    J Infect; 2021 Mar; 82(3):e38-e41. PubMed ID: 33248220
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital.
    Clementi N; Ferrarese R; Tonelli M; Amato V; Racca S; Locatelli M; Lippi G; Silvestri G; Clementi M; Mancini N
    Clin Chem Lab Med; 2020 Aug; 58(9):1573-1577. PubMed ID: 32598306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome.
    Salto-Alejandre S; Berastegui-Cabrera J; Camacho-Martínez P; Infante-Domínguez C; Carretero-Ledesma M; Crespo-Rivas JC; Márquez E; Lomas JM; Bueno C; Amaya R; Lepe JA; Cisneros JM; Pachón J; Cordero E; Sánchez-Céspedes J;
    Sci Rep; 2021 Jun; 11(1):12931. PubMed ID: 34155307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loads.
    Bolze A; Luo S; White S; Cirulli ET; Wyman D; Dei Rossi A; Machado H; Cassens T; Jacobs S; Schiabor Barrett KM; Tanudjaja F; Tsan K; Nguyen J; Ramirez JM; Sandoval E; Wang X; Wong D; Becker D; Laurent M; Lu JT; Isaksson M; Washington NL; Lee W
    Cell Rep Med; 2022 Mar; 3(3):100564. PubMed ID: 35474739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19.
    Miller EH; Annavajhala MK; Chong AM; Park H; Nobel YR; Soroush A; Blackett JW; Krigel A; Phipps MM; Freedberg DE; Zucker J; Sano ED; Uhlemann AC; Abrams JA
    Microbiol Spectr; 2021 Oct; 9(2):e0005521. PubMed ID: 34643448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva.
    Yoon JG; Yoon J; Song JY; Yoon SY; Lim CS; Seong H; Noh JY; Cheong HJ; Kim WJ
    J Korean Med Sci; 2020 May; 35(20):e195. PubMed ID: 32449329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omicron (B.1.1.529) SARS-CoV-2 viral load among nasopharyngeal and oral samples compared to other variants of concern and impact on diagnostic testing strategy.
    Matic N; Lowe CF; Ritchie G; Young M; Lawson T; Romney MG
    Clin Microbiol Infect; 2022 Sep; 28(9):1302-1303. PubMed ID: 35568306
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 Presence in the Saliva, Tears, and Cerumen of COVID-19 Patients.
    Hanege FM; Kocoglu E; Kalcioglu MT; Celik S; Cag Y; Esen F; Bayindir E; Pence S; Alp Mese E; Agalar C
    Laryngoscope; 2021 May; 131(5):E1677-E1682. PubMed ID: 33094833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower nasopharyngeal viral loads in pediatric population. The missing piece to understand SARS-CoV-2 infection in children?
    Cendejas-Bueno E; Romero-Gómez MP; Escosa-García L; Jiménez-Rodríguez S; Mingorance J; García-Rodríguez J;
    J Infect; 2021 Aug; 83(2):e18-e19. PubMed ID: 34133963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of nasopharyngeal SARS-CoV-2 viral load reduction in outpatients with COVID-19.
    Parienti JJ; de Grooth HJ
    J Antimicrob Chemother; 2022 Jun; 77(7):2038-2039. PubMed ID: 35380667
    [No Abstract]   [Full Text] [Related]  

  • 20. Regarding Use of Povidone Iodine to Reduce Nasopharyngeal Viral Load in Patients With COVID-19.
    Singh A; Yadav M; Sikka K
    JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):680-681. PubMed ID: 33914069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.